Search results for ' PRICE DR'

IFSC relaxation may boost trade in foreign stocks at the GIFT City

IFSC relaxation may boost trade in foreign stocks at the GIFT City

Rediff.com8 May 2023

The Reserve Bank of India's (RBI's) decision on Wednesday to relax restrictions on banks operating in the International Financial Services Centre (IFSC) related to the repatriation of idle funds in foreign currency accounts (FCA) could give a fillip to trading in foreign stocks at the GIFT City.

Mamata to stage dharna over Centre's 'discrimination'

Mamata to stage dharna over Centre's 'discrimination'

Rediff.com21 Mar 2023

She claimed that the Centre has not released funds for the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) project for the state and other initiatives of its housing and road departments.

Key mantra for India's pharma sector in 2023

Key mantra for India's pharma sector in 2023

Rediff.com21 Dec 2022

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.

With Elections Near, Debate On Freebies Rages

With Elections Near, Debate On Freebies Rages

Rediff.com19 Sep 2023

Populism gains momentum during election periods, and this trend is evident in at least four states: Telangana, Rajasthan, Madhya Pradesh and Chhattisgarh.

Nasal Covid Vaccine Available In Jan

Nasal Covid Vaccine Available In Jan

Rediff.com28 Dec 2022

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Rediff.com13 Sep 2022

Anti-infectives like Ivermectin, Mupirocin and Meropenem have also been added to the list, taking the total drugs under it to 384.

Noted economist Abhijit Sen, advocate of MSP, passes away

Noted economist Abhijit Sen, advocate of MSP, passes away

Rediff.com30 Aug 2022

Economist Abhijit Sen, a former Planning Commission member and one of the country's foremost experts on rural economy, died on Monday night. He was 72.

Power stocks to stay charged as heat wave sweeps India, say analysts

Power stocks to stay charged as heat wave sweeps India, say analysts

Rediff.com5 May 2023

As temperatures soar across the country, amid searing heat wave, analysts see power demand hitting fresh record highs this year. The time, therefore, may be opportune to add related stocks on dips as higher demand boosts earnings visibility, they said. On April 18, India's electricity demand touched a new high of 216 gigawatts.

Trading Traps: Small Investors Beware!

Trading Traps: Small Investors Beware!

Rediff.com15 Jun 2023

Influenced by ads like 'Make money sitting at home', 'Make Rs 10 lakh with just Rs 1,000', to YouTube influencers promoting 'pump-and-dump' stocks, a vast majority of small investors who mushroomed during the COVID-19 period are losing money in reckless overtrading in the market, cautions Dr V K Vijaykumar, Chief Investment Strategist at Geojit Financial Services.

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Rediff.com22 Oct 2012

Dr Reddy's has offered a price of 0.52 euro in cash for each OctoPlus share.

Markets end in red; Sensex down 391 points

Markets end in red; Sensex down 391 points

Rediff.com13 Oct 2022

Mixed earnings and not so encouraging macroeconomic data dented sentiment, Ajit Mishra, VP - Research, Religare Broking Ltd said. In twin blows to Indian economic revival, higher food prices drove retail inflation to a five-month high of 7.4 per cent, while factory output fell for the first time in 18 months. The second consecutive month of rise in consumer price index (CPI)-based inflation will add to the pressure on the Reserve Bank of India (RBI) to again raise interest rates to tame high prices. In the broader market, BSE Midcap declined 0.73 per cent while smallcap dropped 0.45 per cent.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

Sensex pares early gains as IT stocks crack

Sensex pares early gains as IT stocks crack

Rediff.com9 Dec 2022

Equity benchmark Sensex declined nearly 390 points on Friday, pressured by heavy selling in IT, tech and energy stocks despite a positive trend in the global markets. Besides, rising crude oil prices and relentless foreign capital outflows further weighed on sentiment, traders said. The 30-share BSE Sensex opened strong but came under severe selling pressure to close 389.01 points or 0.62 per cent lower at 62,181.67.

'The story of inflation is not yet over'

'The story of inflation is not yet over'

Rediff.com6 Jun 2023

'The actions of Indian monetary authorities will depend on how quickly they want the inflation to come down to 4 per cent.'

Sensex, Nifty end in red; IT, banking shares drop

Sensex, Nifty end in red; IT, banking shares drop

Rediff.com14 Jul 2022

Benchmark indices Sensex and Nifty gave up early gains to close lower for a fourth straight session on Thursday due to selling in IT and banking shares amid weak global equities. The 30-share BSE benchmark settled 98 points or 0.18 per cent lower at 53,416.15. During the day, it hit a high of 53,861.28 and a low of 53,163.77. The broader NSE Nifty also pared initial gains and ended 28 points or 0.18 per cent down to settle at 15,938.65.

'Hum Bharatiya INDIA ke saath'

'Hum Bharatiya INDIA ke saath'

Rediff.com31 Aug 2023

The contrast between the two meetings couldn't have been more stark, yet, both were organically linked, the latter a show of support for the former.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Sensex slips 94 pts; Nifty falls to 16,569 level

Sensex slips 94 pts; Nifty falls to 16,569 level

Rediff.com6 Jun 2022

Markets continued to fall on Monday, with the Sensex declining 94 points as investors remained cautious amid unabated selling by foreign funds and elevated crude oil prices ahead of the RBI's policy decision later this week. The 30-share BSE Sensex declined 93.91 points or 0.17 per cent to end at 55,675.32. During the day, it tanked 473.49 points or 0.84 per cent to 55,295.74.

Did Climate Change Matter In Gujarat Elections?

Did Climate Change Matter In Gujarat Elections?

Rediff.com8 Dec 2022

Better living conditions must be an integral part of all political campaigns. But this will only happen if the public pressures the political class to understand the irreversibility of climate change and make the environment a crucial part of their manifestos.

Modi 2.0 Ministry Rejig: Who's In, Who's Out

Modi 2.0 Ministry Rejig: Who's In, Who's Out

Rediff.com7 Jul 2021

Several Union ministers, including Health Minister Dr Harsh Vardhan, Education Minister Ramesh Pokhriyal Nishank and Labour Minister Santosh Gangwar resigned.

Naik flays hike in LPG prices

Naik flays hike in LPG prices

Rediff.com16 Jun 2004

Former Petroleum Minister and senior Bharatiya Janata Party leader Ram Naik on Wednesday flayed the Congress-led government for raising the LPG prices, saying the burden on the common man could have been avoided by cutting duties.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

What have I done to earn 'Dr Terror' tag, asks Zakir Naik

What have I done to earn 'Dr Terror' tag, asks Zakir Naik

Rediff.com11 Sep 2016

In a four-page 'open letter' released in Mumbai, Naik posed five questions to the government.

Sensex climbs 465 points; Nifty ends above 17,500

Sensex climbs 465 points; Nifty ends above 17,500

Rediff.com8 Aug 2022

The 30-share BSE gauge climbed 465.14 points or 0.80 per cent to finish at 58,853.07. During the day, it jumped 546.97 points or 0.93 per cent to 58,934.90.

Ahead of talks, Jaishankar hosts reception for visiting ministers

Ahead of talks, Jaishankar hosts reception for visiting ministers

Rediff.com1 Mar 2023

A day ahead of a crucial G20 meeting, External Affairs Minister S Jaishankar on Wednesday evening hosted a welcome dinner for the foreign ministers attending the deliberations but the reception was missed by his counterparts from the US, China, Germany and France.

Jaishankar meets Russian FM Lavrov ahead of G20 meet

Jaishankar meets Russian FM Lavrov ahead of G20 meet

Rediff.com1 Mar 2023

External Affairs Minister S Jaishankar on Wednesday held wide-ranging talks with his Russian counterpart Sergey Lavrov focusing on the Ukraine conflict, bilateral ties and issues relating to the G20 foreign ministers' meeting.

Can Fat Removal Surgery Lead To Death?

Can Fat Removal Surgery Lead To Death?

Rediff.com25 May 2022

Cosmetic experts explain how liposuction, like any other surgery, has its share of risks and side effects.

'If we want to fly some kites, we can fly them in different ways'

'If we want to fly some kites, we can fly them in different ways'

Rediff.com10 Feb 2023

'... and without necessarily calling them Economic Surveys.' 'One should stick to the main focus, which is to give people a good perspective on how the economy is doing.'

Investors' wealth tumbles Rs 86,742 cr as stocks plunge

Investors' wealth tumbles Rs 86,742 cr as stocks plunge

Rediff.com2 Mar 2022

Investors' wealth tumbled Rs 86,741.74 crore on Wednesday, mirroring weakness in the global equity markets amid escalating tensions between Russia and Ukraine. The BSE benchmark Sensex slumped 1,227.18 points to 55,020.10 during the day in line with a global selloff. It finally settled at 55,468.90, lower by 778.38 points or 1.38 per cent. Surging crude prices and foreign capital outflows also weighed on investor sentiment.

Mercedes SUV Mistry was in did not have airbags at the back

Mercedes SUV Mistry was in did not have airbags at the back

Rediff.com5 Sep 2022

The Mercedes-Benz GLC 220d 4MATIC, the SUV former Tata Sons chairman Cyrus Mistry was riding in on Sunday, comes with various safety features to protect passengers but just like other high-end cars, it has no airbags for rear seats.

Govt cornered Left, Right & Centre on fuel price

Govt cornered Left, Right & Centre on fuel price

Rediff.com2 Jul 2009

Much before the honeymoon ended with the public, the Manmohan Singh government delivered a shock in the form of the fuel price hike -- an act of confident UPA -- to compensate the losses of 2010 Union budget.

3 lakh remdesivir to be produced daily in 15 days: Govt

3 lakh remdesivir to be produced daily in 15 days: Govt

Rediff.com18 Apr 2021

The government has also given permission to 20 plants to produce the antiviral drug.

A Memorable Dinner With Aamir Khan

A Memorable Dinner With Aamir Khan

Rediff.com30 Mar 2023

By refusing to follow the pack and remain politically correct, Aamir Khan has paid a price. A fascinating excerpt from Shobhaa De's new book, Insatiable.

Good news for heart patients: Stent prices reduced by 85%!

Good news for heart patients: Stent prices reduced by 85%!

Rediff.com16 Feb 2017

Aneesh Phadnis and Veena Mani find out what the manufacturers and the hospitals have to say.

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Rediff.com1 Sep 2022

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.

Sputnik V jabs to be available in 9 more cities across India

Sputnik V jabs to be available in 9 more cities across India

Rediff.com17 Jun 2021

Russian COVID-19 vaccine Sputnik V vaccine will be available in nine more cities across India, including Bengaluru, Mumbai, Chennai, Visakhapatnam, Baddi, Kolhapur and Miryalaguda, informed the official twitter handle of Sputnik V.

Why 27,000 Litres Of Ganga Jal Was Carried to London

Why 27,000 Litres Of Ganga Jal Was Carried to London

Rediff.com6 May 2023

When Jaipur's Maharaja Madho Singh was invited to attend King Edward VII's coronation in 1902, he chartered a ship for Rs 15 lakh for the journey. He also carried 27,000 litres of Ganga jal on board. Prakash Bhandari recalls the maharaja's voyage to attend a British monarch's coronation on a day when Charles III will be crowned king at Westminster Abbey.

Markets extend rally to 3rd day; Sensex climbs over 300 points

Markets extend rally to 3rd day; Sensex climbs over 300 points

Rediff.com8 Jul 2022

Benchmark indices gained for the third day running on Friday, with the Sensex climbing over 300 points amid mixed global market trends. The 30-share BSE benchmark advanced 303.38 points or 0.56 per cent to settle at 54,481.84. During the day, it jumped 448.68 points or 0.82 per cent to 54,627.14. The broader NSE Nifty went higher by 87.70 points or 0.54 per cent to end at 16,220.60.

Markets zoom nearly 2%; Sensex jumps 1,181 points at close

Markets zoom nearly 2%; Sensex jumps 1,181 points at close

Rediff.com11 Nov 2022

Equity benchmarks Sensex and Nifty on Friday spurted by nearly 2 per cent, propelled by heavy buying in IT, metal and financial stocks amid a rally in global markets after lower-than-expected US inflation data. A strong rupee against the US dollar and unabated foreign capital inflows further bolstered sentiment, traders said. Easing US inflation triggered speculation that the US Federal Reserve might slow down the pace of interest rate hikes.

Covid vaccine could cost up to Rs 1000 in private market

Covid vaccine could cost up to Rs 1000 in private market

Rediff.com28 Apr 2021

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.